Search research articles
Contact Us
Filters
Showing results (91-100 of 155) with videos related to
Page
of 16
Sort By:
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
September 22, 2007
Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors
Maryam A Farinola, Allen M Gown, Kara Judson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 8, 2009
The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression
Andrea Proctor Subhawong, Christopher M Heaphy, Pedram Argani, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
March 5, 2008
Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement
Kara Judson, Colleen McCormick, Russell Vang, et al.
The American Journal of Surgical Pathology
|
April 20, 2013
Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively
Christopher J Vandenbussche, Nagi Khouri, Eman Sbaity, et al.
Oncotarget
|
July 1, 2021
Correction: <i>BRAF</i> -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
M Herman Chui, Susanne K Kjaer, Kirsten Frederiksen, et al.
The Journal of Pathology
|
October 13, 2011
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions
Elisabetta Kuhn, Robert J Kurman, Russell Vang, et al.
Gynecologic Oncology
|
January 22, 2017
Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study
Emma L Kaderly Rasmussen, Charlotte Gerd Hannibal, Christian Dehlendorff, et al.
Human Pathology
|
September 6, 2017
Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma
Deyin Xing, Yohan Suryo Rahmanto, Felix Zeppernick, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 10, 2018
Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus
Gang Zheng, Abby Richmond, Chengbao Liu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 9, 2020
Coexistence of Conventional Leiomyoma, Fumarate Hydratase-deficient Atypical Leiomyoma, and Perivascular Epithelioid Cell Tumor in a Uterus: A Case Study
Yuehua Liu, Essel Marie B DeLeon, Salman Okour, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 155) with videos related to
Sort By:
Page
of 16
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
September 22, 2007
Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors
Maryam A Farinola, Allen M Gown, Kara Judson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 8, 2009
The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression
Andrea Proctor Subhawong, Christopher M Heaphy, Pedram Argani, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
March 5, 2008
Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement
Kara Judson, Colleen McCormick, Russell Vang, et al.
The American Journal of Surgical Pathology
|
April 20, 2013
Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively
Christopher J Vandenbussche, Nagi Khouri, Eman Sbaity, et al.
Oncotarget
|
July 1, 2021
Correction: <i>BRAF</i> -mutated ovarian serous borderline tumors are at relatively low risk for progression to serous carcinoma
M Herman Chui, Susanne K Kjaer, Kirsten Frederiksen, et al.
The Journal of Pathology
|
October 13, 2011
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions
Elisabetta Kuhn, Robert J Kurman, Russell Vang, et al.
Gynecologic Oncology
|
January 22, 2017
Parity, infertility, oral contraceptives, and hormone replacement therapy and the risk of ovarian serous borderline tumors: A nationwide case-control study
Emma L Kaderly Rasmussen, Charlotte Gerd Hannibal, Christian Dehlendorff, et al.
Human Pathology
|
September 6, 2017
Mutation of NRAS is a rare genetic event in ovarian low-grade serous carcinoma
Deyin Xing, Yohan Suryo Rahmanto, Felix Zeppernick, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 10, 2018
Clinicopathologic Features and Genetic Alterations of a Primary Osteosarcoma of the Uterine Corpus
Gang Zheng, Abby Richmond, Chengbao Liu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
|
April 9, 2020
Coexistence of Conventional Leiomyoma, Fumarate Hydratase-deficient Atypical Leiomyoma, and Perivascular Epithelioid Cell Tumor in a Uterus: A Case Study
Yuehua Liu, Essel Marie B DeLeon, Salman Okour, et al.
Page
of 16